|  | Cancer | Cancer Treatment

Targeted Cancer Therapy: Mechanisms, Benefits, and Advances

How Targeted Therapy Differs from Chemotherapy

Traditional chemotherapy attacks all rapidly dividing cells, harming healthy tissues. Targeted therapy homes in on specific molecular alterations driving cancer growth, sparing normal cells and reducing side effects.

1. Molecular Targets

Cancer cells often harbor mutations, amplifications, or overexpression of proteins (e.g., HER2, EGFR, BCR-ABL, ALK, BRAF) that fuel proliferation and survival. These become the "bull's-eye" for drug development.

2. Drug Design

Using structural biology and genomics, scientists engineer small molecules or monoclonal antibodies to inhibit a target's function—blocking signaling, triggering apoptosis, or flagging cells for immune destruction.

3. Administration Routes

Oral (pills) or intravenous (IV) delivery depends on the drug's properties. Oral agents offer convenience; IV infusions allow controlled dosing and monitoring.

4. Key Mechanisms of Action

  • Growth inhibition: Block cell-cycle progression (e.g., CDK4/6 inhibitors).
  • Apoptosis induction: Activate programmed cell death (e.g., BCL-2 inhibitors).
  • Anti-angiogenesis: Starve tumors by preventing new blood vessel formation (e.g., VEGF inhibitors).
  • Signal transduction blockade: Interrupt oncogenic pathways (e.g., EGFR, ALK, BRAF inhibitors).
  • Immune engagement: Antibody-drug conjugates or bispecific antibodies recruit immune cells.

5. Specificity and Precision Medicine

By matching drugs to a tumor's genomic profile (via biopsy or liquid biopsy), oncologists practice precision oncology—selecting the most effective agent for each patient's unique cancer.

6. Combination Strategies

Targeted agents often pair with chemotherapy, immunotherapy, or radiation to attack cancer through multiple mechanisms simultaneously, delaying resistance.

7. Monitoring and Resistance Management

Regular imaging and liquid biopsies track response. Upon progression, repeat genomic profiling identifies resistance mutations (e.g., EGFR T790M), guiding next-line therapy.

Outlook: Targeted therapy has revolutionized oncology, turning some lethal cancers into chronic conditions. Ongoing research aims to overcome resistance, expand targetable alterations, and broaden access.

Cancer Treatment - Related Articles